Granules India Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
GRANULES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts less than Nifty Smallcap 250 and 1.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Granules India Limited has filed its financial results for the quarter and financial year ended March 31, 2025 with the stock exchange. This is a routine compliance filing under SEBI listing requirements. The filing confirms that the audited financial statements for FY25 are now publicly available for investor review. Investors will need to look at the detailed results document to assess the company's performance, including revenue, profit, and margin trends.
No immediate price impact expected from the filing itself; the actual numbers in the results will determine market reaction. Investors should review the detailed financial statement for revenue growth, margins, and profitability trends.